Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Sept 2024 for G1 Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Garry A. Nicholson: trading record in brief
This profile gathers the share dealings of Garry A. Nicholson across 2 companies, led by G1 Therapeutics, Inc. and TESARO, Inc. The record holds 8 filings, for trades running from 1 June 2016 to 18 September 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 18 September 2024, reports a transaction in G1 Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Garry A. Nicholson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
20,000 sharesCommon StockSEC:0000950170-24-107797:0
10,000 shares0Common StockSEC:0001562180-24-005078:0
10,000 shares0Common StockSEC:0001562180-23-005264:0
10,000 shares0Common StockSEC:0001562180-22-005353:0
4,389 shares0Common StockSEC:0001562180-21-004393:0
5 of 5 declarations
